GlaxoSmithKline plc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline plc with three other
companies in this sector in UNITED STATES :
sales of $45.80 billion
of which 100%
was pharmaceutical products),
Bristol-Myers Squibb Company
of which 28%
was Prioritized Brands-Revlimid).
During the year ended December of 2020, sales at
GlaxoSmithKline plc were $44.07 billion.
increase of 2.1%
versus 2019, when the company's sales were $43.18 billion.
This was the fifth consecutive year of sales increases at GlaxoSmithKline plc
(and since 2015, sales have increased a total of 21%).